ML234
Product Specifications
Target
Histone Methyltransferase
Related Pathways
Chromatin/Epigenetic
Bioactivity
ML234 is a dual inhibitor targeting EZH2/LSD1, with IC50 values of 0.09 and 0.12 μM, respectively. It demonstrates strong antiproliferative effects on prostate cancer cell lines LNCAP, PC3, and 22RV1. Additionally, ML234 inhibits tumor growth in a 22RV1 xenograft mouse model, showing potential as a research agent in prostate cancer therapeutics.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9439096-01 0.1 mL (Biotin)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details MBS9439096-02 0.1 mL (AF350)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details MBS9439096-03 0.1 mL (AF405)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details 
MBS9439096-04 0.1 mL (AF488)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details 
MBS9439096-05 0.1 mL (AF555)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details MBS9439096-06 0.1 mL (AF594)
IL18 Binding Protein Conjugated Monoclonal Antibody
Sign In for Pricing
View Details